These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1965897)

  • 1. Protective effects of dopexamine hydrochloride in renal failure after acute haemorrhage in anaesthetized dogs.
    Chintala MS; Lokhandwala MF; Jandhyala BS
    J Auton Pharmacol; 1990; 10 Suppl 1():s95-102. PubMed ID: 1965897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effects of dopexamine, a novel DA1 receptor and beta 2-adrenoceptor agonist, on cardiac function and splanchnic circulation in a canine model of hemorrhagic shock.
    Chintala MS; Moore RJ; Lokhandwala MF; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):296-300. PubMed ID: 8097568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal failure in haemorrhagic shock in dogs: salutary effects of the calcium entry blocker felodipine.
    Chintala MS; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):357-63. PubMed ID: 2333102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and mechanisms of dopexamine in the prevention of ischemia-reperfusion induced organ damage: role of oxygen free radicals.
    Jacinto SM; Chintala MS; Lokhandwala MF; Jandhyala BS
    Clin Exp Hypertens; 1997; 19(1-2):181-90. PubMed ID: 9028645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical, autoradiographic and pharmacological evidence for the involvement of tubular DA-1 receptors in the natriuretic response to dopexamine hydrochloride.
    Vyas SJ; Apparsundaram S; Ricci A; Amenta F; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):21-30. PubMed ID: 1674360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
    Smith GW; Hall JC; Farmer JB; Simpson WT
    J Pharm Pharmacol; 1987 Aug; 39(8):636-41. PubMed ID: 2888855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human renovascular effects of dopexamine hydrochloride: a novel agonist of peripheral dopamine and beta 2-adreno-receptors.
    Magrini F; Foulds R; Roberts N; Macchi G; Mondadori C; Zanchetti A
    Eur J Clin Pharmacol; 1987; 32(1):1-4. PubMed ID: 2884113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy of felodipine in two models of acute renal failure in dogs.
    Chintala MS; Jandhyala BS
    Kidney Int Suppl; 1992 May; 36():S94-9. PubMed ID: 1614075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic effects of dopexamine hydrochloride in the canine kidney.
    Bass AS
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):33-6. PubMed ID: 1347154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney.
    Bass AS
    J Pharmacol Exp Ther; 1990 May; 253(2):798-802. PubMed ID: 1971021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride.
    Goldberg LI; Bass AS
    Am J Cardiol; 1988 Aug; 62(5):37C-40C. PubMed ID: 2841837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors.
    Bakris GL; Lass NA; Glock D
    Kidney Int; 1999 Jul; 56(1):206-10. PubMed ID: 10411694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel orally active dopamine (DA) prodrug TA-870. IV. Renal vasodilatory and negative chronotropic effects in anesthetized dogs: influence of DA1 and DA2 dopamine receptor selective antagonists.
    Nishiyama S; Yoshikawa M; Yamaguchi I
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):560-7. PubMed ID: 1711621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs.
    Neustein SM; Dimich I; Sampson I; Sadeghi A; Mezrow C; Shiang H
    Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of atrial natriuretic factor are independent of dopamine1 receptors.
    Murphy MB; Bass AS; Goldberg LI
    Am J Physiol; 1988 Sep; 255(3 Pt 2):F494-9. PubMed ID: 2970800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride).
    Smith GW; O'Connor SE
    Am J Cardiol; 1988 Aug; 62(5):9C-17C. PubMed ID: 2900602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of dopamine and dopexamine in the newborn anesthetized rabbit.
    Jaton T; Thonney M; Gouyon JB; Guignard JP
    Life Sci; 1992; 50(3):195-202. PubMed ID: 1346227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.
    Martin SW; Broadley KJ
    Br J Pharmacol; 1994 Jun; 112(2):595-603. PubMed ID: 7915614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.